Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.2M
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
10M
-
Shares change
-
-387K
-
Total reported value, excl. options
-
$87M
-
Value change
-
-$3.38M
-
Number of buys
-
20
-
Number of sells
-
-13
-
Price
-
$8.73
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q1 2016
41 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q1 2016.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10M shares
of 55.2M outstanding shares and own 18.15% of the company stock.
Largest 10 shareholders include FMR LLC (3.9M shares), BROOKSIDE CAPITAL MANAGEMENT LLC (1.52M shares), WELLINGTON MANAGEMENT GROUP LLP (954K shares), Partner Fund Management, L.P. (894K shares), GOLDMAN SACHS GROUP INC (798K shares), Casdin Capital, LLC (339K shares), JANUS CAPITAL MANAGEMENT LLC (305K shares), EVENTIDE ASSET MANAGEMENT, LLC (300K shares), DEERFIELD MANAGEMENT CO (235K shares), and BlackRock Fund Advisors (147K shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.